BACKGROUND: Between 10% and 20% of patients with neuroendocrine tumors (NETs) present with metastases of unknown primary site. Because knowledge of the primary site has important implications for treatment, we set out to define gene-expression profiles to differentiate between small-bowel NETs (SBNETs) and pancreatic NETs (PNETs). METHODS: RNA was extracted from tumor and normal tissues in 11 patients with SBNETs and 15 patients with PNETs, and qPCR was performed for 367 GPCR genes. Differentially expressed genes were identified using the RT2 Profiler. Whole genome expression analysis was performed on 11 SBNETs, 5 PNETS, and corresponding normal tissues. Statistical significance was evaluated by the Student t test and ANOVA. RESULTS: Whole-genome analysis revealed 173 significantly differentially expressed genes in SBNETs and normal tissues and in 52 in PNETs. GPCR arrays identified 28 genes in SBNETs and 18 in PNETs, with significant expression differences from normal tissues. In all SBNETs, 2 genes were significantly upregulated by more than fivefold: OXTR and GPR113. No PNETs shared this profile, whereas 73% had a greater than fivefold downregulation of ADORA1 and SCTR. These genes also allowed for determination of the primary site in 8 of 10 liver metastases. CONCLUSION: Differential expression patterns using as few as 2 to 4 GPCR genes successfully discriminated primary sites in small bowel and pancreatic NETs.
BACKGROUND: Between 10% and 20% of patients with neuroendocrine tumors (NETs) present with metastases of unknown primary site. Because knowledge of the primary site has important implications for treatment, we set out to define gene-expression profiles to differentiate between small-bowel NETs (SBNETs) and pancreatic NETs (PNETs). METHODS: RNA was extracted from tumor and normal tissues in 11 patients with SBNETs and 15 patients with PNETs, and qPCR was performed for 367 GPCR genes. Differentially expressed genes were identified using the RT2 Profiler. Whole genome expression analysis was performed on 11 SBNETs, 5 PNETS, and corresponding normal tissues. Statistical significance was evaluated by the Student t test and ANOVA. RESULTS: Whole-genome analysis revealed 173 significantly differentially expressed genes in SBNETs and normal tissues and in 52 in PNETs. GPCR arrays identified 28 genes in SBNETs and 18 in PNETs, with significant expression differences from normal tissues. In all SBNETs, 2 genes were significantly upregulated by more than fivefold: OXTR and GPR113. No PNETs shared this profile, whereas 73% had a greater than fivefold downregulation of ADORA1 and SCTR. These genes also allowed for determination of the primary site in 8 of 10 liver metastases. CONCLUSION: Differential expression patterns using as few as 2 to 4 GPCR genes successfully discriminated primary sites in small bowel and pancreatic NETs.
Authors: G Capurso; S Lattimore; T Crnogorac-Jurcevic; F Panzuto; M Milione; V Bhakta; N Campanini; S M Swift; C Bordi; G Delle Fave; N R Lemoine Journal: Endocr Relat Cancer Date: 2006-06 Impact factor: 5.678
Authors: Anne Couvelard; Jiangting Hu; Graham Steers; Dermot O'Toole; Alain Sauvanet; Jacques Belghiti; Pierre Bedossa; Kevin Gatter; Philippe Ruszniewski; Francesco Pezzella Journal: Gastroenterology Date: 2006-09-08 Impact factor: 22.682
Authors: Sam C Wang; Justin R Parekh; Marlene B Zuraek; Alan P Venook; Emily K Bergsland; Robert S Warren; Eric K Nakakura Journal: Arch Surg Date: 2010-03
Authors: Eric Raymond; Laetitia Dahan; Jean-Luc Raoul; Yung-Jue Bang; Ivan Borbath; Catherine Lombard-Bohas; Juan Valle; Peter Metrakos; Denis Smith; Aaron Vinik; Jen-Shi Chen; Dieter Hörsch; Pascal Hammel; Bertram Wiedenmann; Eric Van Cutsem; Shem Patyna; Dongrui Ray Lu; Carolyn Blanckmeister; Richard Chao; Philippe Ruszniewski Journal: N Engl J Med Date: 2011-02-10 Impact factor: 91.245
Authors: James C Yao; Manisha H Shah; Tetsuhide Ito; Catherine Lombard Bohas; Edward M Wolin; Eric Van Cutsem; Timothy J Hobday; Takuji Okusaka; Jaume Capdevila; Elisabeth G E de Vries; Paola Tomassetti; Marianne E Pavel; Sakina Hoosen; Tomas Haas; Jeremie Lincy; David Lebwohl; Kjell Öberg Journal: N Engl J Med Date: 2011-02-10 Impact factor: 91.245
Authors: Mark Bloomston; Alan Durkin; Ivana Yang; Mumtaz Rojiani; Alexander S Rosemurgy; Steven Enkmann; Timothy J Yeatman; Emmanuel E Zervos Journal: Ann Surg Oncol Date: 2004-04 Impact factor: 5.344
Authors: Edoardo Missiaglia; Irene Dalai; Stefano Barbi; Stefania Beghelli; Massimo Falconi; Marco della Peruta; Lorenzo Piemonti; Gabriele Capurso; Alessia Di Florio; Gianfranco delle Fave; Paolo Pederzoli; Carlo M Croce; Aldo Scarpa Journal: J Clin Oncol Date: 2009-11-16 Impact factor: 44.544
Authors: William G Dilley; Somasundaram Kalyanaraman; Sulekha Verma; J Perren Cobb; Jason M Laramie; Terry C Lairmore Journal: Mol Cancer Date: 2005-02-03 Impact factor: 27.401
Authors: Jennifer C Carr; Scott K Sherman; Donghong Wang; Fadi S Dahdaleh; Andrew M Bellizzi; M Sue O'Dorisio; Thomas M O'Dorisio; James R Howe Journal: Ann Surg Oncol Date: 2013-10-10 Impact factor: 5.344
Authors: Scott K Sherman; Jessica E Maxwell; Jennifer C Carr; Donghong Wang; M Sue O'Dorisio; Thomas M O'Dorisio; James R Howe Journal: J Surg Res Date: 2014-01-29 Impact factor: 2.192
Authors: Paul A Insel; Andrea Wilderman; Alexander C Zambon; Aaron N Snead; Fiona Murray; Nakon Aroonsakool; Daniel S McDonald; Shu Zhou; Thalia McCann; Lingzhi Zhang; Krishna Sriram; Amy M Chinn; Alexander V Michkov; Rebecca M Lynch; Aaron C Overland; Ross Corriden Journal: Mol Pharmacol Date: 2015-03-03 Impact factor: 4.436
Authors: Scott K Sherman; Jennifer C Carr; Donghong Wang; M Sue O'Dorisio; Thomas M O'Dorisio; James R Howe Journal: Surgery Date: 2013-12 Impact factor: 3.982
Authors: Scott K Sherman; Jessica E Maxwell; Jennifer C Carr; Donghong Wang; Andrew M Bellizzi; M Sue O'Dorisio; Thomas M O'Dorisio; James R Howe Journal: Clin Exp Metastasis Date: 2014-09-21 Impact factor: 5.150
Authors: John F Tierney; Jennifer Poirier; Sitaram Chivukula; Sam G Pappas; Martin Hertl; Erik Schadde; Xavier Keutgen Journal: Int J Endocrinol Date: 2019-03-12 Impact factor: 3.257